rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1999-10-20
|
pubmed:abstractText |
Vitamin D analogues such as 1 alpha (OH) D3 (alphacalcidiol) have a possible physiological paracrine effect on cell proliferation and differentiation. Experimentally established possibilities to prevent autoimmune diseases suggest that alphacalcidiol may have therapeutic value as an immunomodulatory agent in patients with rheumatoid arthritis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-856X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
453-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10464556-Adjuvants, Immunologic,
pubmed-meshheading:10464556-Adult,
pubmed-meshheading:10464556-Aged,
pubmed-meshheading:10464556-Antirheumatic Agents,
pubmed-meshheading:10464556-Apoptosis,
pubmed-meshheading:10464556-Arthritis, Rheumatoid,
pubmed-meshheading:10464556-Calcifediol,
pubmed-meshheading:10464556-Calcium,
pubmed-meshheading:10464556-Cell Division,
pubmed-meshheading:10464556-Cells, Cultured,
pubmed-meshheading:10464556-Female,
pubmed-meshheading:10464556-Follow-Up Studies,
pubmed-meshheading:10464556-Humans,
pubmed-meshheading:10464556-Lymphocytes,
pubmed-meshheading:10464556-Male,
pubmed-meshheading:10464556-Middle Aged,
pubmed-meshheading:10464556-Phytohemagglutinins,
pubmed-meshheading:10464556-Treatment Outcome
|
pubmed:articleTitle |
Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients.
|
pubmed:affiliation |
Department of Rheumatology, Military Medical Academy, Belgrade, Yugoslavia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|